Emergent offers specialized products to healthcare providers and governments to address public health threats and emerging infectious diseases.
Auto-injector platform
The Emergard® auto-injector platform is designed for intramuscular rapid delivery of nerve agent antidotes and other emergency response medical treatments. The auto-injector can address exposure to certain chemical agents by delivering an antidote to those agents after exposure. This platform is designed for self and buddy administration when used in a military setting and for use by emergency medical personnel in the event of civilian exposure. (Auto-injector is not approved by the U.S. FDA)
Hyperimmunes
Emergent has expertise with FDA-approved human and equine plasma products generated for targeted therapy of specific indications. Our hyperimmune specialty plasma product manufacturing platform has been used to create multiple products that have obtained FDA approval, up to a scale of 1000L.
Human Platform – Purified gamma globulin (IgG) containing polyclonal antibodies to specific antigen(s) obtained from human plasma.
Equine Platform – Purified immune globulin fragments derived from polyclonal antibodies to specific antigen(s) obtained from equine plasma.
Antivirals
Emergent’s broad-spectrum antiviral iminosugars platform uses a mechanism of action that inhibits a host glycosylation pathway resulting in misfolded viral glycoproteins, subsequently leading to reduced viral infectivity. Enveloped viruses are potential targets, with treatment of acute Dengue illness currently in clinical development.
Antimicrobials
Emergent’s EV-035 series of broad spectrum antibiotics have a novel 4-oxoquinolizine antibacterial backbone showing activity against quinolone-resistant bacterial strains
Trademark Legend
Emergent BioSolutions®, ACAM2000® , Anthrasil®, BAT®, BioThrax®, Emergard®,RSDL® , CNJ-016®, Vivotif®,Vaxchora®, and NARCAN®, and any and all Emergent BioSolutions Inc. brand, product, service and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries.